Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: 8 | Vintage Vibes

As a medicines regulator, we are committed to ending drugs shortages

Letter: Dr June Raine of the MHRA says the agency is working with industry to improve response times while protecting patient safety

The Guardian - UK

‘They thought they were doing good but it made people worse’: why mental health apps are under scrutiny

As experts worry over privacy issues, ineffectiveness and even harm, the UK is looking at whether the plethora of digital mental health tools need regulating

The Guardian - UK

What is Mounjaro? The new weight-loss drug to be supplied to the UK

Mounjaro may be used to treat obese individuals in a new, convenient form which makes it more accessible

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight loss injection to be made available in UK within weeks

Mounjaro will come in a four-dose device known as a KwikPen for people with type 2 diabetes or obesity

The Guardian - UK

Landmark sickle cell drug axed by regulators

Exclusive: Crizanlizumab was hailed as first new drug to be introduced in over 20 years for people living with sickle cell disease

The Independent UK

New Regulatory Roadmap To Uphold Patient Safety in UK Medical Devices

The MHRA has launched a new regulatory roadmap that will help make future regulations for UK medical devices keeping in mind patient safety and their ability to harness medical technology advancements.

International Business Times UK

What is the prescription drug clozapine and is it dangerous?

Clozapine is said to be prescribed for around 37,000 Brits a year but can cause toxicity

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Use ‘mothballed’ Covid mega lab to help tackle antibiotic resistance, MPs urge

The Rosalind Franklin Laboratory – which has received more than £1 billion of public funding – is currently on sale on Rightmove.

The Independent UK

Breakthrough Treatment Veoza Receives UK Approval to Tackle Hot Flushes

Veoza distinguishes itself as a non-hormonal menopause drug that directly targets the brain to prevent hot flushes.

International Business Times UK

A 'game-changing' new drug for hot flushes has just been approved: what does this mean for UK women?

Veoza is the new drug for hot flushes that's been approved for use in the UK with immediate effect

Woman & Home

The era of CRISPR therapeutics is here – what can we expect? | Explained

Two geneticists explain the groundbreaking CRISPR-based therapies approved for sickle-cell disease and β-thalassaemia, and other genetic therapeutics in development, including base-editing and prime-editing.

The Hindu

3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Acorda Therapeutics, Inc. (ACOR) could be ideal additions to your portfolio this week. Read more….

StockNews.com

The world's 1st CRISPR therapy has just been approved. Here's everything you need to know

U.K. regulators have approved the use of a CRISPR therapy called Casgevy to treat two inherited blood disorders. But what is it and how does it work?

LiveScience

The First CRISPR Gene Therapy Was Finally Approved In The US — Here’s How It Works

Using the gene editing tool CRISPR, the new therapy promises a cure for those with sickle cell anemia and beta thalassemia, but cost could be a barrier to care.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Blood disorder breakthrough as world-first gene therapy given green light

The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020

The Independent UK

World-first gene therapy for inherited blood disorders approved in UK

The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020.

Woman & Home

What is anastrozole? All you need to know about the new breast cancer drug

Anastrozole has the potential to reduce the risk of breast cancer by almost 50% for many postmenopausal women at risk, here's what you need to know

The Independent UK

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Private health firm Sciensus fails to fix defects that led to UK patient’s death

Exclusive: Regulator extends part suspension of licence to July 2024 after IT blunder led to incorrect dosage of cancer treatment

The Guardian - UK

Functional fungi: can medicinal mushrooms really improve people’s health?

The boom in sales of mushroom products has led to many claims for their wellbeing and curative properties, but is there any scientific evidence to back them up?

Evening Standard

Urgent warning over counterfeit Ozempic after hospitalisations

Medicines regulator seizes 369 potentially fake devices amid surge in demand

The Independent UK

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

The Guardian - UK

UK public warned over dangers of fake weight loss medication pens

Pre-filled injection devices claimed to hold Ozempic or Saxenda may contain other substances, regulator says

The Times of India

Taking cholesterol-reducing pills? Serious side effects you need to know

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

The Guardian - UK

‘These patients do not have time’: families in UK demand access to new drug that slows brain tumours

Vorasidenib worked in trials but is not yet available on the NHS

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals Incorporated

65 stories

Vertex Pharmaceuticals

59 stories

the National Institute for Health and Care Excellence

28 stories

Replika

24 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.